DUXAP8 and hepatocellular carcinoma: Research has indicated that DUXAP8 can diminish the sensitivity of HCC to ferroptosis induced by sorafenib, a type of programmed cell death, by influencing the expression of the solute carrier family 7 member 11 (SLC7A11) gene.125